FDA-Cleared vs FDA-Approved: What Hair Device Labels Mean

“FDA-cleared” and “FDA-approved” are different legal events, and the gap between them is where laser-cap marketing lives. Approval — the path new drugs take — requires the manufacturer to prove effectiveness to FDA's satisfaction. Clearance requires the manufacturer to show its device is substantially equivalent to a device already on the market. Every laser cap, comb and helmet sold for hair growth carries the second kind, and this reading shows you how to check any device's real record in about two minutes.

What a 510(k) clearance actually is

FDA's own definition, from its Premarket Notification page (read 23 September 2026): a 510(k) is “a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device.” The operative machinery is the predicate: the maker points at an earlier cleared device with the same intended use and technology and argues sameness. The chain regresses — today's cap cleared against a 2018 cap, which cleared against a 2013 helmet, and so on back toward the earliest cleared laser phototherapy devices — and at no link in that chain did FDA run the kind of efficacy review the word “approved” implies. This is a legitimate, standard pathway for lower-risk devices; the sleight of hand is purely in the advertising that upgrades it.

Look up any device yourself

FDA's 510(k) database is public and searchable. Searching it on 23 September 2026 gives the real records behind the brands on our laser cap for hair growth page:

• Theradome: K122950 (“Laser Helmet,” June 2013) and K171775 (LH80 PRO, January 2018), plus K180460 (LH40, May 2018) — filed under Theradome, Inc.
• iRestore: K151662 (January 2016), K183417 (Professional 282, May 2019), K213094 (ID-500, December 2021) and K222081 (ID-510 Elite, October 2022) — filed under Freedom Laser Therapy, Inc.
• Kiierr: K181878 (September 2018), one filing covering the Kiierr 272 and 148.
• illumiflow: K162071 (February 2017) and K173843 (148 Laser Cap, January 2018) — filed under Eglobal, LLC, not under a company named illumiflow. OEM filings like this are normal and legal; they are also exactly the kind of detail “FDA-cleared!” banners never volunteer.

The exercise generalizes: any brand's “FDA-cleared” claim should resolve to a K-number you can find. If a vendor can't or won't name its K-number, that silence is the answer.

What approval would have required instead

The comparison isn't hypothetical — it is the other pathway in the same statute. Premarket approval (PMA), the route required for high-risk devices and the standard new drugs meet by analogy, obliges the maker to submit valid scientific evidence of safety and effectiveness for FDA's own review before marketing. No hair-growth cap has gone that route; the category rides the 510(k) lane, where FDA's decision letter literally reads “Substantially Equivalent” — that exact phrase is the decision recorded on the Theradome LH80 PRO's file (K171775, product code OAP, reviewed under the Physical Medicine panel; database read 23 September 2026). Equivalence chains are how a 2022 helmet inherits standing from a 2013 one: each link argues sameness to the link before, and the efficacy question passes down the chain unexamined rather than answered.

The tier below clearance: nothing at all

Clearance-versus-approval is not even the whole ladder — below both sits the general wellness lane, where gadgets avoid FDA device review entirely by claiming only vague wellbeing rather than treatment of a condition. Red-light combs and brushes sold with soft-focus language and no K-number live there. The practical test is unchanged and takes two minutes: a device claiming to treat hair loss should name a K-number that resolves in FDA's public database, the way every device on our assessment page does. No K-number plus a treatment claim is the worst square on the board — a medical promise that never met even the sameness filter.

The claims police is the FTC, and it has been here

Because clearance says nothing about efficacy, the fight over what device ads may claim happens at the FTC and the advertising self-regulator NAD — and the laser-cap category has a file. The National Advertising Division referred Capillus LLC's advertising for its Capillus 82 laser cap to the FTC, recording that Capillus had agreed to follow NAD's recommendations in August 2017 but “was unwilling to make additional modifications to its advertisements in 2018.” The FTC's staff closing letter of 16 June 2020 declined to recommend enforcement, citing among its factors “the FDA's findings of substantial equivalency for certain products, and Capillus's discontinuation or modification of certain claims” — and closed with the standard, pointed reservation:

“Staff's decision not to recommend enforcement action at this time and to close the investigation is not to be construed as a determination that a violation of law did not occur.” — FTC staff closing letter re Capillus LLC, ftc.gov, 16 June 2020

The point here is bigger than one brand: in a category where the regulator of record has already processed a referral about growth claims, the reader's default should be to trust filings and trials, not adjectives.

How to read a hair-device box, in one paragraph

“FDA-cleared” means: a filing exists; the device matched a predicate; nobody at FDA vouched for regrowth. “Clinically proven” means: ask which clinic, which trial, published where — if the answer isn't a citation, it's a slogan. A K-number means you can check the record yourself in the public database. And a price means exactly what it says — which is why our device table pairs every clearance record with the store price on a stated date, and why the safety reading treats trial-reported adverse events, not marketing reassurances, as the safety record. Two minutes in a public database is cheap insurance on a four-figure purchase — and a vendor confident in its record will make those two minutes easy.